Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | ESR1 | P03372 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | KDR | P35968 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160420 | 0.90 | ESR1 (0.66) | LMNAESR1TSHRTDP1RAB9A | |
| SCHEMBL7773822 | 0.89 | RAB9A (0.61) | ALDH1A1ESR1TDP1KDM4ERAB9A | |
| SCHEMBL111664 | 0.89 | LMNA (0.75) | LMNAALDH1A1ESR1TSHRCHRM1 | |
| SCHEMBL29709386 | 0.89 | ESR1 (0.59) | LMNAALDH1A1ESR1TSHRTDP1 | |
| SCHEMBL4473542 | 0.89 | ESR1 (0.59) | LMNAALDH1A1ESR1TSHRTDP1 | |
| SCHEMBL1042359 | 0.87 | ESR1 (0.61) | LMNAALDH1A1ESR1TSHRRAB9A | |
| SCHEMBL1038902 | 0.87 | ESR1 (0.61) | LMNAALDH1A1ESR1TSHRRAB9A | |
| SCHEMBL1041379 | 0.87 | ESR1 (0.61) | LMNAALDH1A1ESR1TSHRRAB9A | |
| SCHEMBL22497786 | 0.87 | ESR1 (0.61) | LMNAALDH1A1ESR1TSHRRAB9A | |
| SCHEMBL1040814 | 0.87 | ESR1 (0.61) | LMNAALDH1A1ESR1TSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3946240-B1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO KGAA (DE) | 2025-10-15 | — | — | EP | claimed |
| US-20220211602-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-07-07 | — | — | US | claimed |
| EP-3946240-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-02-09 | — | — | EP | claimed |
| CN-113677319-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | claimed |
| CN-109695038-B | Pickling roll manufacturing process | 浙江协和薄钢科技有限公司 | 2020-10-13 | — | — | CN | claimed |
| WO-2020200545-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2020-10-08 | — | — | WO | claimed |
| CN-109695038-A | Manufacturing process is rolled up in pickling | 浙江协和薄钢科技有限公司 | 2019-04-30 | — | — | CN | claimed |
| CN-117320685-A | Composition for skin protection comprising an antimicrobial agent and a (bio) -alkanediol | 西姆莱斯股份公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116621737-A | Preparation method and application of 6-guanidyl caproyl oxybenzoic acid ester derivative | 天津理工大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116615172-A | Composition comprising a natural polymer and one or more (bio) alkanediols | 西姆莱斯股份公司 | 2023-08-18 | — | — | CN | disclosed |
| US-20220211602-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-07-07 | — | — | US | disclosed |
| EP-3946240-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-02-09 | — | — | EP | disclosed |
| CN-113677319-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | disclosed |
| US-6528164-B1 | Condensation polymerization of 6-oxynaphthalene-2-carboxylic acid derivative and p-oxybenzoic acid derivative; solidification, pulverization, heat treatment | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-04 | — | — | US | disclosed |
| US-6376076-B1 | LOW TEMPERATURE; MELT PROCESSABILITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-23 | — | — | US | disclosed |
| US-6296930-B1 | HEAT-RESISTANCE FOR USE AS WRAPPING MATERIAL AND LOW TEMPERATURE PROCESSABILITY, GAS BARRIER PROPERTY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-10-02 | — | — | US | disclosed |
| EP-1081173-A2 | Process for producing aromatic liquid crystalline polyester and film thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-07 | — | — | EP | disclosed |
| EP-0964014-A2 | Aromatic liquid crystalline polyester resin and resin composition thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| WO-1997036586-A1 | TREATMENT OR PROPHYLAXIS OF DIARRHOEA | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-10-09 | — | — | WO | disclosed |
| US-4051122-A | Disazo pigments containing tetracarboxylic acid ester groups | CIBA-GEIGY CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211602-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | KRT18, CCNA1, CCNA2 | LMNA 123/4885ALDH1A1 185/4885ESR1 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.